Loma Linda University | Loma Linda University Medical Center
Enrollment Information
1-800-422-4LLU (1-800-422-4558)
Loma Linda University Faculty G. Hussein - Professional Activity
Gamal Hussein, PharmD
Position
Assistant Professor of Pharmacy Practice
Biography
PharmD, University of Texas • Residency, University of Texas • BS, Pharmacy, Cairo University, Cairo, Egypt • Clinical Toxicology Fellowship, Cairo • Clinical Pharmacokinetics Fellowship, University of Texas, Galveston
Research Interests
Dr. Hussein is very active in research, publishing, and grant writing. He developed the first multimedia interactive computer program for teaching clinical pharmacokinetics and individualizing drug dosage regimens. This was the precursor to MedStorm software currently owned by AmerisourceBergen. He implemented therapeutic drug monitoring consultation services at several Louisiana hospitals. He is a reviewer, judge, and task force member for a number of professional organizations and projects.
Selected Publications
Hussein G. MedStorm™: Innovative Patient Safety Software for Optimal Therapeutics. Grapevine, TX: Pharmacy Healthcare Solutions, an AmeriSourceBergen Company, 2003.
Hussein G. ICS; An interactive Voice Response System with text to speech capability, Information Communication Systems Publishing, New Orleans, LA 2003.
Hussein G. Practical Pharmacokinetics; An Interactive Computer Program for the Teaching and the Practice of Therapeutic Drug Monitoring, New Orleans, LA: MedProcessor Publishing, 2004.
Hussein G, Kawahara N. Adaptive and Longitudinal Teaching of Pharmaceutical Care: Utilization of Virtual Patients and an Interactive Voice Response/Text to Speech (IVR/TTS) System. Am J Pharm Edu. 2006;2: in press.
Hussein G, Kawahara N. Adaptive and Longitudinal Teaching of Pharmaceutical Care: Utilization of Virtual Patients and an Interactive Voice Response/Text to Speech (IVR/TTS) System. Am J Pharm Edu. 2006;2: in press.
Perkins L, Hussein G, Leung B. Anemia and Erythropoietin (rHuEPO) management program
for optimal therapeutics and patient care. Clinical Research and Regulatory Affairs. Fall 2003;20(3):331-339.
for optimal therapeutics and patient care. Clinical Research and Regulatory Affairs. Fall 2003;20(3):331-339.